• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Is 22q11.2 Deletion Syndrome A Risk Factor for Developing Type 2 Diabetes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • 22q11.2 deletion syndrome (22q11.2DS) affects approximately 1 in 3000 to 4000 live births
    • Manifestations include hypoparathyroidism and hypothyroidism, as well as increased risk of obesity in adults
  • Van et al. (E Clinical Medicine, 2020) assessed whether adults with 22q11.2DS have an increased risk of developing type 2 diabetes (T2D)

METHODS:

  • Cohort study
  • Participants (17 to 69 years)
    • Adults with 22q11.2DS
    • Adults in the general population
  • Exposures
    • 22q11.2DS
  • Study design
    • T2D diagnosis: Based on history and glycosylated hemoglobin (HbA1c)
    • Logistic regression models applied to account for covariates including
      • Age | Sex | Non-European ethnicity | Fmily history of T2D | Obesity | Antipsychotic medication use
  • Primary outcome
    • Risk of T2D

RESULTS:

  • 314 individuals in the 22q11.2DS cohort | 11,874 individuals in a general population cohort
    • Higher BMI and a greater proportion of antipsychotic medications were identified in the 22q11.2DS group vs a population sample (p < 0.0001)
  • 22q11.2DS was a significant independent risk factor for T2D (P<0.0001)
    • OR 2.44 (95% CI, 1.39 to 4.31)
  • Other factors exhibited significant effects, especially non-European ethnicity
  • Median age at diagnosis of T2D was significantly younger in the 22q11.2DS cohort than in the general population (P<0.0001)
    • 22q11.2DS: 32 years
    • General population: 50 years
  • HbA1c was significantly higher in the 22q11.2DS cohort even in those individuals not meeting criteria for T2D diagnosis (P=0.042)

CONCLUSION:

  • 22q11.2DS is an independent risk factor for T2D
  • The results of this study add to a growing body of evidence that rare CNVs may contribute to risk for T2D
  • The authors state

The results allow for screening, anticipatory care, and prevention of T2D for those with known 22q11.2DS

Future research to investigate management of T2D and risk for T2D in this newly identified high-risk population will provide immediately translatable results

Learn More – Primary Sources:

22q11.2 microdeletion and increased risk for type 2 diabetes

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

22q11.2 Deletion Syndrome – Key Clinical Highlights
22q11.2 Deletion Syndrome: Long-Term Mortality Risks and Outcomes
Are CNVs Associated with Miscarriage?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site